Literature DB >> 7843777

Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma.

M Hamada1, Y Shigematsu, M Mukai, Y Kazatani, T Kokubu, K Hiwada.   

Abstract

To elucidate whether a difference in blood pressure reactivity exists between patients with pheochromocytoma (n = 8) and pseudopheochromocytoma (n = 22), we evaluated blood pressure changes during a Valsalva maneuver and baroreceptor reflex sensitivity. We also examined the effects of propranolol and prazosin on blood pressure reactivity during a Valsalva maneuver in patients with pseudopheochromocytoma. Pseudopheochromocytoma was defined as a paroxysmal rise in blood pressure accompanying pheochromocytoma-like symptoms and normal catecholamine values. The difference in systolic blood pressure between phase IV of the Valsalva maneuver and baseline (delta SBP) was markedly smaller in the pheochromocytoma patients (8.4 +/- 18.4 mm Hg) than in the essential hypertension patients (n = 30, 30.9 +/- 19.4 mm Hg) and normotensive control subjects (n = 10, 31.3 +/- 11.4 mm Hg), whereas delta SBP in the pseudopheochromocytoma patients (77.8 +/- 11.2 mm Hg) was markedly greater than in the other three groups. delta SBP was markedly suppressed by the administration of both propranolol and prazosin. Baroreceptor reflex sensitivity index was lower in the pheochromocytoma group than in the other three groups. In conclusion, blood pressure reactivity responses to a Valsalva maneuver are disparate between pheochromocytoma and pseudopheochromocytoma. The high blood pressure reactivity to a Valsalva maneuver in pseudopheochromocytoma is due to hyperactivity in both beta- and alpha 1-adrenergic receptor functions, and the low blood pressure reactivity to a Valsalva maneuver in pheochromocytoma seems to be mainly due to the desensitization of both adrenergic systems associated with chronic catecholamine excess. In addition, the impaired baroreceptor function in pheochromocytoma is partially responsible for it.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843777     DOI: 10.1161/01.hyp.25.2.266

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge.

Authors:  Kelly Dyer; Theresa E Vettese
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

Review 2.  Pseudopheochromocytoma: an Uncommon Cause of Severe Hypertension.

Authors:  Christie G Turin; Debbie L Cohen
Journal:  Curr Cardiol Rep       Date:  2022-01-08       Impact factor: 2.931

3.  Pheochromocytoma crisis presenting with cardiogenic shock.

Authors:  Y S Chatzizisis; A Ziakas; C Feloukidis; D Paramythiotis; S Hadjimiltiades; A Iliadis; G Basdanis; I Styliadis
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

4.  Pheochromocytoma crisis with severe cyclic blood pressure fluctuations in a cardiac pheochromocytoma patient successfully resuscitated by extracorporeal membrane oxygenation: a case report.

Authors:  Xiang Zhou; Dawei Liu; Longxiang Su; Yun Long; Wei Du; Qi Miao; Fang Li; Zhengyu Jin; Zhengpei Zeng; Ailun Luo; Yuguang Huang
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

5.  Lateralizing sensorimotor deficits in a case of pseudopheochromocytoma.

Authors:  Joome Suh; Courtney Quinn; Alia Rehwinkel
Journal:  Yale J Biol Med       Date:  2014-12-12

6.  Pseudopheochromocytoma Associated with Domestic Assault.

Authors:  H M Le; G Carbutti; D Ilisei; E Bouccin; X Vandemergel
Journal:  Case Rep Cardiol       Date:  2016-09-21

7.  Pseudopheochromocytoma induced by anxiolytic withdrawal.

Authors:  Alida Páll; Gergely Becs; Annamária Erdei; Lívia Sira; Arpád Czifra; Sándor Barna; Péter Kovács; Dénes Páll; György Pfliegler; György Paragh; Zoltán Szabó
Journal:  Eur J Med Res       Date:  2014-10-08       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.